Alvotech (ALVO) Other Accumulated Expenses (2020 - 2026)
Alvotech's (ALVO) quarterly Other Accumulated Expenses came in at $92.3 million in Q1 2026, up 42.86% YoY from $64.6 million in Q1 2025, and down 2.04% on a QoQ basis from $94.2 million in Q4 2025.
Alvotech (ALVO) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has 7 years of Other Accumulated Expenses data on file, last reported at $92.3 million in Q1 2026.
- Quarterly Other Accumulated Expenses rose 42.86% year-over-year to $92.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92.3 million (up 42.86% YoY) and the FY2025 annual result came in at $94.2 million, up 58.62% from the prior year.
- Other Accumulated Expenses slipped to $92.3 million in Q1 2026, from $94.2 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $100.4 million in Q3 2025 to a low of $50.5 million in Q3 2024.
- A 5-year average of $72.7 million and a median of $70.0 million in 2022 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2024 — Other Accumulated Expenses fell 27.1% — and 2025, when it jumped 98.72%.
- Tracing ALVO's Other Accumulated Expenses over 5 years: stood at $54.0 million in 2022, then climbed by 16.05% to $62.7 million in 2023, then retreated by 5.29% to $59.4 million in 2024, then surged by 58.62% to $94.2 million in 2025, then dropped by 2.04% to $92.3 million in 2026.
- The last three Other Accumulated Expenses figures came in at $92.3 million (Q1 2026), $94.2 million (Q4 2025), and $100.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92.31 Mn |
| Dec 31, 2025 | 94.23 Mn |
| Sep 30, 2025 | 100.38 Mn |
| Jun 30, 2025 | 73.14 Mn |
| Mar 31, 2025 | 64.61 Mn |
| Dec 31, 2024 | 59.40 Mn |
| Sep 30, 2024 | 50.51 Mn |
| Jun 30, 2024 | 62.46 Mn |
| Mar 31, 2024 | 76.01 Mn |
| Dec 31, 2023 | 62.72 Mn |
| Jun 30, 2023 | 85.68 Mn |
| Mar 31, 2023 | 75.10 Mn |
| Dec 31, 2022 | 54.05 Mn |
| Jun 30, 2022 | 66.83 Mn |
| Dec 31, 2021 | 42.01 Mn |
| Dec 31, 2020 | 16.42 Mn |